MeSH Review:
Glioma
Silva,
Laszlo,
Cioffi,
Jacks,
Bourtchuladze,
Lazlo,
Frankland,
Friedman,
Marowitz,
Holland,
Dai,
Schaefer,
Fuller,
Celestino,
Sawaya,
Holland,
DePinho,
Hively,
Varmus,
James J. Vredenburgh,
Jennifer A. Quinn,
Melissa Wagner,
Jeremy N. Rich,
Jeannette M. Dowell,
Allan H. Friedman,
James E. Herndon,
David A. Reardon,
Annick Desjardins,
Henry S. Friedman,
Sith Sathornsumetee,
Sridharan Gururangan,
Darell D. Bigner,
Yamazaki,
Nakamura,
Tsuchida,
Ueyama,
Kijima,
Abe,
Ohnishi,
Oshika,
Tamaoki,
Tsugu,
Tokunaga,
Boado,
Zhang,
Pardridge,
Li,
Nagaya,
Duffau,
Kujas,
Taillandier,
Debinski,
Obiri,
Gibo,
Puri,
Kealiher,
Patrick Roth,
Marcos Tatagiba,
Michael Weller,
Michel Mittelbronn,
Richard Meyermann,
Wolfgang Wick,
Furnari,
Huang,
Lin,
Cavenee,
- Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors. Aronin, P.A., Mahaley, M.S., Rudnick, S.A., Dudka, L., Donohue, J.F., Selker, R.G., Moore, P. N. Engl. J. Med. (1980)
- A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Silva, A.J., Frankland, P.W., Marowitz, Z., Friedman, E., Laszlo, G.S., Cioffi, D., Jacks, T., Bourtchuladze, R., Lazlo, G. Nat. Genet. (1997)
- Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Dewey, R.A., Morrissey, G., Cowsill, C.M., Stone, D., Bolognani, F., Dodd, N.J., Southgate, T.D., Klatzmann, D., Lassmann, H., Castro, M.G., Löwenstein, P.R. Nat. Med. (1999)
- Cellular interactions uncouple beta-adrenergic receptors from adenylate cyclase. Ciment, G., de Vellis, J. Science (1978)
- Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Su, Z.Z., Leszczyniecka, M., Kang, D.C., Sarkar, D., Chao, W., Volsky, D.J., Fisher, P.B. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2). Michel, D., Chabot, J.G., Moyse, E., Danik, M., Quirion, R. Synapse (1992)
- Episodic nocturnal wandering in a patient with epilepsy due to a right temporoinsular low-grade glioma: relief following resection. Case report. Duffau, H., Kujas, M., Taillandier, L. J. Neurosurg. (2006)
- Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Pollack, I.F., Campbell, J.W., Hamilton, R.L., Martinez, A.J., Bozik, M.E. Cancer (1997)
- Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S.N., Hidalgo, O.F., Vanaclocha, V., Baylin, S.B., Herman, J.G. N. Engl. J. Med. (2000)
- Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Holland, E.C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R.E., Fuller, G.N. Nat. Genet. (2000)
- Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. Walker, M.D., Green, S.B., Byar, D.P., Alexander, E., Batzdorf, U., Brooks, W.H., Hunt, W.E., MacCarty, C.S., Mahaley, M.S., Mealey, J., Owens, G., Ransohoff, J., Robertson, J.T., Shapiro, W.R., Smith, K.R., Wilson, C.B., Strike, T.A. N. Engl. J. Med. (1980)
- Noradrealine induces morphological alterations in nucleated and enucleated rat C6 glioma cells. Oey, J. Nature (1975)
- Glutamate release promotes growth of malignant gliomas. Takano, T., Lin, J.H., Arcuino, G., Gao, Q., Yang, J., Nedergaard, M. Nat. Med. (2001)
- External cyclic AMP-dependent protein kinase activity in rat C-6 glioma cells. Schlaeger, E., Köhler, G. Nature (1976)
- Muscarinic response to acetylcholine in neuroblastoma times glioma hybrid cells. Traber, J., Fischer, K., Buchen, C., Hamprecht, B. Nature (1975)
- Morphine elevates levels of cyclic GMP in a neuroblastoma X glioma hybrid cell line. Gullis, R., Traber, J., Hamprecht, B. Nature (1975)
- Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Vredenburgh, J.J., Desjardins, A., Herndon, J.E., Dowell, J.M., Reardon, D.A., Quinn, J.A., Rich, J.N., Sathornsumetee, S., Gururangan, S., Wagner, M., Bigner, D.D., Friedman, A.H., Friedman, H.S. Clin. Cancer Res. (2007)
- Increased glioma growth in mice depleted of macrophages. Galarneau, H., Villeneuve, J., Gowing, G., Julien, J.P., Vallières, L. Cancer Res. (2007)
- A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Iwamaru, A., Szymanski, S., Iwado, E., Aoki, H., Yokoyama, T., Fokt, I., Hess, K., Conrad, C., Madden, T., Sawaya, R., Kondo, S., Priebe, W., Kondo, Y. Oncogene (2007)
- Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. McConville, P., Hambardzumyan, D., Moody, J.B., Leopold, W.R., Kreger, A.R., Woolliscroft, M.J., Rehemtulla, A., Ross, B.D., Holland, E.C. Clin. Cancer Res. (2007)
- Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Kim, E.H., Sohn, S., Kwon, H.J., Kim, S.U., Kim, M.J., Lee, S.J., Choi, K.S. Cancer Res. (2007)
- DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas. Okemoto, K., Kasai, K., Wagner, B., Haseley, A., Meisen, H., Bolyard, C., Mo, X., Wehr, A., Lehman, A., Fernandez, S., Kaur, B., Chiocca, E.A. Clin. Cancer Res. (2013)
- Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Fueyo, J., Gomez-Manzano, C., Yung, W.K., Liu, T.J., Alemany, R., McDonnell, T.J., Shi, X., Rao, J.S., Levin, V.A., Kyritsis, A.P. Nat. Med. (1998)
- Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Dobrowsky, R.T., Werner, M.H., Castellino, A.M., Chao, M.V., Hannun, Y.A. Science (1994)
- PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Dai, C., Celestino, J.C., Okada, Y., Louis, D.N., Fuller, G.N., Holland, E.C. Genes Dev. (2001)
- Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. Chenevert, T.L., Stegman, L.D., Taylor, J.M., Robertson, P.L., Greenberg, H.S., Rehemtulla, A., Ross, B.D. J. Natl. Cancer Inst. (2000)
- Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression. Yamazaki, H., Kijima, H., Ohnishi, Y., Abe, Y., Oshika, Y., Tsuchida, T., Tokunaga, T., Tsugu, A., Ueyama, Y., Tamaoki, N., Nakamura, M. J. Natl. Cancer Inst. (1998)
- Subpopulations of cultured chick sympathetic neurones differ in their requirements for survival factors. Edgar, D., Barde, Y.A., Thoenen, H. Nature (1981)
- Effects of sodium warfarin and sodium heparin plus anticancer agents on growth of rat C6 glioma cells. McNiel, N.O., Morgan, L.R. J. Natl. Cancer Inst. (1984)
- Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. Kuratsu, J., Yoshizato, K., Yoshimura, T., Leonard, E.J., Takeshima, H., Ushio, Y. J. Natl. Cancer Inst. (1993)
- Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas. Elliott, L., Brooks, W., Roszman, T. J. Natl. Cancer Inst. (1987)
- A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Holland, E.C., Hively, W.P., DePinho, R.A., Varmus, H.E. Genes Dev. (1998)
- Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. Weller, M., Frei, K., Groscurth, P., Krammer, P.H., Yonekawa, Y., Fontana, A. J. Clin. Invest. (1994)
- Novel anti-brain tumor cytotoxins specific for cancer cells. Debinski, W., Gibo, D.M., Obiri, N.I., Kealiher, A., Puri, R.K. Nat. Biotechnol. (1998)
- Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Furnari, F.B., Lin, H., Huang, H.S., Cavenee, W.K. Proc. Natl. Acad. Sci. U.S.A. (1997)
- Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Hermansson, M., Nistér, M., Betsholtz, C., Heldin, C.H., Westermark, B., Funa, K. Proc. Natl. Acad. Sci. U.S.A. (1988)
- High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Bruna, A., Darken, R.S., Rojo, F., Ocaña, A., Peñuelas, S., Arias, A., Paris, R., Tortosa, A., Mora, J., Baselga, J., Seoane, J. Cancer. Cell (2007)
- Participation of the chaperone Hsc70 in the trafficking and functional expression of ASIC2 in glioma cells. Vila-Carriles, W.H., Zhou, Z.H., Bubien, J.K., Fuller, C.M., Benos, D.J. J. Biol. Chem. (2007)
- Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Liu, Y., Zhang, H., Zhou, K., Chen, L., Xu, Z., Zhong, Y., Liu, H., Li, R., Shugart, Y.Y., Wei, Q., Jin, L., Huang, F., Lu, D., Zhou, L. Carcinogenesis (2007)
- Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1. Roth, P., Mittelbronn, M., Wick, W., Meyermann, R., Tatagiba, M., Weller, M. Cancer Res. (2007)
- ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Jarzynka, M.J., Hu, B., Hui, K.M., Bar-Joseph, I., Gu, W., Hirose, T., Haney, L.B., Ravichandran, K.S., Nishikawa, R., Cheng, S.Y. Cancer Res. (2007)
- Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Kong, L.Y., Wu, A.S., Doucette, T., Wei, J., Priebe, W., Fuller, G.N., Qiao, W., Sawaya, R., Rao, G., Heimberger, A.B. Clin. Cancer Res. (2010)
- Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Fulda, S., Wick, W., Weller, M., Debatin, K.M. Nat. Med. (2002)
- Evaluating glioma therapies: modeling treatments and predicting outcomes. Kirby, S., Brothers, M., Irish, W., Florell, R., Macdonald, D., Schold, C., Cairncross, G. J. Natl. Cancer Inst. (1995)
- Cell cycle changes in the adenylate cyclase of C6 glioma cells. Howard, R.F., Sheppard, J.R. J. Cell Biol. (1981)
- Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. Liang, Y., Häring, M., Roughley, P.J., Margolis, R.K., Margolis, R.U. J. Cell Biol. (1997)
- Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Boado, R.J., Li, J.Y., Nagaya, M., Zhang, C., Pardridge, W.M. Proc. Natl. Acad. Sci. U.S.A. (1999)